These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

713 related items for PubMed ID: 24835277

  • 1. Gene-specific increase in the energetic cost of contraction in hypertrophic cardiomyopathy caused by thick filament mutations.
    Witjas-Paalberends ER, Güçlü A, Germans T, Knaapen P, Harms HJ, Vermeer AM, Christiaans I, Wilde AA, Dos Remedios C, Lammertsma AA, van Rossum AC, Stienen GJ, van Slegtenhorst M, Schinkel AF, Michels M, Ho CY, Poggesi C, van der Velden J.
    Cardiovasc Res; 2014 Jul 15; 103(2):248-57. PubMed ID: 24835277
    [Abstract] [Full Text] [Related]

  • 2. Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy.
    Witjas-Paalberends ER, Piroddi N, Stam K, van Dijk SJ, Oliviera VS, Ferrara C, Scellini B, Hazebroek M, ten Cate FJ, van Slegtenhorst M, dos Remedios C, Niessen HW, Tesi C, Stienen GJ, Heymans S, Michels M, Poggesi C, van der Velden J.
    Cardiovasc Res; 2013 Aug 01; 99(3):432-41. PubMed ID: 23674513
    [Abstract] [Full Text] [Related]

  • 3. Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations.
    Sequeira V, Wijnker PJ, Nijenkamp LL, Kuster DW, Najafi A, Witjas-Paalberends ER, Regan JA, Boontje N, Ten Cate FJ, Germans T, Carrier L, Sadayappan S, van Slegtenhorst MA, Zaremba R, Foster DB, Murphy AM, Poggesi C, Dos Remedios C, Stienen GJ, Ho CY, Michels M, van der Velden J.
    Circ Res; 2013 May 24; 112(11):1491-505. PubMed ID: 23508784
    [Abstract] [Full Text] [Related]

  • 4. Faster cross-bridge detachment and increased tension cost in human hypertrophic cardiomyopathy with the R403Q MYH7 mutation.
    Witjas-Paalberends ER, Ferrara C, Scellini B, Piroddi N, Montag J, Tesi C, Stienen GJ, Michels M, Ho CY, Kraft T, Poggesi C, van der Velden J.
    J Physiol; 2014 Aug 01; 592(15):3257-72. PubMed ID: 24928957
    [Abstract] [Full Text] [Related]

  • 5. Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations.
    Olivotto I, Girolami F, Sciagrà R, Ackerman MJ, Sotgia B, Bos JM, Nistri S, Sgalambro A, Grifoni C, Torricelli F, Camici PG, Cecchi F.
    J Am Coll Cardiol; 2011 Aug 16; 58(8):839-48. PubMed ID: 21835320
    [Abstract] [Full Text] [Related]

  • 6. Troponin T and beta-myosin mutations have distinct cardiac functional effects in hypertrophic cardiomyopathy patients without hypertrophy.
    Revera M, van der Merwe L, Heradien M, Goosen A, Corfield VA, Brink PA, Moolman-Smook JC.
    Cardiovasc Res; 2008 Mar 01; 77(4):687-94. PubMed ID: 18029407
    [Abstract] [Full Text] [Related]

  • 7. Myocardial Deformation Analysis in MYBPC3 and MYH7 Related Sarcomeric Hypertrophic Cardiomyopathy-The Graz Hypertrophic Cardiomyopathy Registry.
    Höller V, Seebacher H, Zach D, Schwegel N, Ablasser K, Kolesnik E, Gollmer J, Waltl G, Rainer PP, Verheyen S, Zirlik A, Verheyen N.
    Genes (Basel); 2021 Sep 23; 12(10):. PubMed ID: 34680864
    [Abstract] [Full Text] [Related]

  • 8. Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage.
    Viswanathan SK, Sanders HK, McNamara JW, Jagadeesan A, Jahangir A, Tajik AJ, Sadayappan S.
    PLoS One; 2017 Sep 23; 12(11):e0187948. PubMed ID: 29121657
    [Abstract] [Full Text] [Related]

  • 9. Screening of MYH7, MYBPC3, and TNNT2 genes in Brazilian patients with hypertrophic cardiomyopathy.
    Marsiglia JD, Credidio FL, de Oliveira TG, Reis RF, Antunes Mde O, de Araujo AQ, Pedrosa RP, Barbosa-Ferreira JM, Mady C, Krieger JE, Arteaga-Fernandez E, Pereira Ada C.
    Am Heart J; 2013 Oct 23; 166(4):775-82. PubMed ID: 24093860
    [Abstract] [Full Text] [Related]

  • 10. Expression patterns of cardiac myofilament proteins: genomic and protein analysis of surgical myectomy tissue from patients with obstructive hypertrophic cardiomyopathy.
    Theis JL, Bos JM, Theis JD, Miller DV, Dearani JA, Schaff HV, Gersh BJ, Ommen SR, Moss RL, Ackerman MJ.
    Circ Heart Fail; 2009 Jul 23; 2(4):325-33. PubMed ID: 19808356
    [Abstract] [Full Text] [Related]

  • 11. Genetic diagnosis of hypertrophic cardiomyopathy using mass spectrometry DNA arrays and high resolution melting.
    Santos S, Lança V, Oliveira H, Branco P, Silveira L, Marques V, Brito D, Madeira H, Bicho M, Fernandes AR.
    Rev Port Cardiol; 2011 Jan 23; 30(1):7-18. PubMed ID: 21425739
    [Abstract] [Full Text] [Related]

  • 12. Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations.
    Girolami F, Ho CY, Semsarian C, Baldi M, Will ML, Baldini K, Torricelli F, Yeates L, Cecchi F, Ackerman MJ, Olivotto I.
    J Am Coll Cardiol; 2010 Apr 06; 55(14):1444-53. PubMed ID: 20359594
    [Abstract] [Full Text] [Related]

  • 13. Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic Cardiomyopathy.
    Toepfer CN, Garfinkel AC, Venturini G, Wakimoto H, Repetti G, Alamo L, Sharma A, Agarwal R, Ewoldt JK, Cloonan P, Letendre J, Lun M, Olivotto I, Colan S, Ashley E, Jacoby D, Michels M, Redwood CS, Watkins HC, Day SM, Staples JF, Padrón R, Chopra A, Ho CY, Chen CS, Pereira AC, Seidman JG, Seidman CE.
    Circulation; 2020 Mar 10; 141(10):828-842. PubMed ID: 31983222
    [Abstract] [Full Text] [Related]

  • 14. A Contraction Stress Model of Hypertrophic Cardiomyopathy due to Sarcomere Mutations.
    Cohn R, Thakar K, Lowe A, Ladha FA, Pettinato AM, Romano R, Meredith E, Chen YS, Atamanuk K, Huey BD, Hinson JT.
    Stem Cell Reports; 2019 Jan 08; 12(1):71-83. PubMed ID: 30554920
    [Abstract] [Full Text] [Related]

  • 15. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.
    Girolami F, Olivotto I, Passerini I, Zachara E, Nistri S, Re F, Fantini S, Baldini K, Torricelli F, Cecchi F.
    J Cardiovasc Med (Hagerstown); 2006 Aug 08; 7(8):601-7. PubMed ID: 16858239
    [Abstract] [Full Text] [Related]

  • 16. Lifelong Clinical Impact of the Presence of Sarcomere Gene Mutation in Japanese Patients With Hypertrophic Cardiomyopathy.
    Nakashima Y, Kubo T, Sugiura K, Ochi Y, Takahashi A, Baba Y, Hirota T, Yamasaki N, Kimura A, Doi YL, Kitaoka H.
    Circ J; 2020 Sep 25; 84(10):1846-1853. PubMed ID: 32830170
    [Abstract] [Full Text] [Related]

  • 17. Unexpectedly low mutation rates in beta-myosin heavy chain and cardiac myosin binding protein genes in Italian patients with hypertrophic cardiomyopathy.
    Roncarati R, Latronico MV, Musumeci B, Aurino S, Torella A, Bang ML, Jotti GS, Puca AA, Volpe M, Nigro V, Autore C, Condorelli G.
    J Cell Physiol; 2011 Nov 25; 226(11):2894-900. PubMed ID: 21302287
    [Abstract] [Full Text] [Related]

  • 18. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.
    Sedaghat-Hamedani F, Kayvanpour E, Tugrul OF, Lai A, Amr A, Haas J, Proctor T, Ehlermann P, Jensen K, Katus HA, Meder B.
    Clin Res Cardiol; 2018 Jan 25; 107(1):30-41. PubMed ID: 28840316
    [Abstract] [Full Text] [Related]

  • 19. Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction.
    Timmer SA, Germans T, Brouwer WP, Lubberink M, van der Velden J, Wilde AA, Christiaans I, Lammertsma AA, Knaapen P, van Rossum AC.
    Eur J Heart Fail; 2011 Dec 25; 13(12):1283-9. PubMed ID: 22021246
    [Abstract] [Full Text] [Related]

  • 20. A new common mutation in the cardiac beta-myosin heavy chain gene in Finnish patients with hypertrophic cardiomyopathy.
    Jääskeläinen P, Heliö T, Aalto-Setälä K, Kaartinen M, Ilveskoski E, Hämäläinen L, Melin J, Kärkkäinen S, Peuhkurinen K, Nieminen MS, Laakso M, FinHCM Study Group, Kuusisto J.
    Ann Med; 2014 Sep 25; 46(6):424-9. PubMed ID: 24888384
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.